Homšek, A. et al. (2022) “Assessment of pembrolizumab exposure in different patient subpopulations using pharmacometric simulation”, Archives of Pharmacy, 72(Suppl. 4), pp. S227-S228. Available at: https://test.aseestant.ceon.rs/index.php/arhfarm/article/view/38447 (Accessed: 19 November 2026).